• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China’s Recent Measures for the Urgent Approval of Medical and Health Products Amid Coronavirus Outbreak

China’s Recent Measures for the Urgent Approval of Medical and Health Products Amid Coronavirus Outbreak

Tuesday, 28 January 2020 / Published in Medical Device

China’s Recent Measures for the Urgent Approval of Medical and Health Products Amid Coronavirus Outbreak

On 23.01.2020, the Ministry of Commerce of the PRC announced (No.3-2020) the list of intermediary services and administrative examinations and approvals for import and export of goods.

The China Chamber of Commerce for Import & Export of Medicines and Health Products continues to be responsible for the import quota monitoring of restricted goods in accordance with regulations of the Public Bidding Measures on Quota of Export Commodities and Detailed Implementation Regulations of Public Bidding on Industry Products Export Quota.

With the aim to promote integrated development of domestic and foreign trade under a well-established management system, this measure supports the reform to delegate power, streamline administration and optimize government services.

On 30.01.2020, the Yunnan Medical Products Administration announced the urgent need to import overseas medical devices to China due to the Coronavirus outbreak, and the NMPA registration process can be omitted if the following requirements are met:

– The medical device meets the US, EU, and Japan standards with a proof of overseas certification and a declaration of product safety and quality

– The medical device is considered necessary by the provincial government in China for the emergency to control the epidemic

As of 05.02.2020, the provincial counterparts of the NMPA had approved the importation even without NMPA approval for 72 categories of medical products, including:

– 2 Medical Masks
– 14 Surgical Masks, 17 Single-use Medical Masks
– 9 Single-use Medical Protective Clothing, 10 Single-use Surgical Clothing
– 2 Reusable Surgical Clothing
– 2 Single-use Medical Caps
– 1 Single-use Surgical Cap
– 1 Medical Isolation Bed
– 1 Isolation Cabin
– 1 Single-use Surgical Napkin Package
– 1 Single-use Sterile Surgical Sheet
– 1 Single-use Medical Examination Glove
– 1 Single-use Surgical Glove
– 1 Noninvasive Ventilator
– 1 Nasal Catheter
– 1 Heating Breathing Pipe
– 1 Infrared Thermometer
– 1 High-flow Humidification Apparatus
– 1 Digital Mobile X-ray Machine
– 1 Single-use Interventional Operation Package
– 1 Single-use Endotracheal Intubation Package
– 1 Single-use Sputum Suction Package

Although the NMPA registration process can be omitted, the new measure aims to strengthen the surveillance of the overseas medical devices before the import certification is issued. During the expedited registration process, the confirmation of approval must be acquired from the Medical Products Administration (MPA) at the provincial level to complete the customs clearance, in order to ensure the product safety and quality of the imported medical devices.

On 07.02.2020, SAMR (CNCA) announced that there are a total of 55 testing and inspection institutions nationally recognized for their testing capabilities on medical devices and personal protective equipment to support the epidemic prevention and control of the latest Coronavirus infection.

The number of institutions are listed with the respective testing capability in the table below:

Number of Testing / Inspection Institutions

Testing Capability

30

Single-use medical protective clothing

(Class II)

34

Surgical Mask

(Class II)

28

Medical Protective Mask

(Class II)

24

Medical Isolation Mask

(Class I)

34

Single-use Medical Rubber Examination Gloves

(Sterile Gloves – Class II)

(Non-sterile Gloves – Class I)

34

Single-use Rubber Sterile Surgical Gloves

(Class II)

In addition, there are another 170 testing and inspection institutions provincially recognized for the testing capabilities of personal protective equipment. Feel free to contact us if you would like to receive more information about the testing and inspection institutions.

On 07.02.2020, the National Medical Products Administration (NMPA) announced (No.71-2020) a list of measures to expedite the approval process of medical protective clothing to prevent the Coronavirus from spreading by:

–           Encouraging the expansion of the production capacity in newly added factory sites

–           Encouraging factories of other product categories to switch to produce medical protective clothing

–           Optimizing the procedures for the registration and production of medical protective clothing

–           Assigning personnel from the relevant government departments to help enterprises meet the requirements sooner

The measures announced on 07.02.2020 are temporary for the current emergency situation and will be lifted after the epidemic is over.

Tagged under: SAMR

What you can read next

Product Technical Requirements
Medical Device Product Technical Requirements – New Guideline Issued
Clinical Trials GMP management
Use of Overseas Clinical Trial Data for IVDs
Webinar: Opportunities in China’s Medical Device Market

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...
  • China medical device quality safety responsibility

    China medical device quality and safety responsibility regulations come into force on March 1, 2023

    China medical device quality and safety respons...
  • China drug standards draft measures

    China drug standards draft measures have been published by the NMPA

    China drug standards draft measures have recent...
  • China special equipment safety supervision

    China special equipment safety supervision – draft provisions released

    China special equipment safety supervision regu...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.